Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-29

Clinical Trial Update: Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating sulfamylon 5% topical solution in burns, comparing to a historical control; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfamylon 5% Topical Solution (mafenide acetate)

Snippet

Sponsor: Mylan Inc. | Conditions: Burns | Phase 4 | Status: TERMINATED | Results posted: 2014-09-29